INTRODUCTION

Multidrug-resistant TB (MDR-TB) caused by
Mycobacterium tuberculosis resistant to both isoniazid and rifampicin with or without resistance to other drugs is among the most worrisome elements of the pandemic of antibiotic resistance because TB patients that fail treatment have a high risk of death (1) . Globally, about three percent of all newly diagnosed patients have MDR-TB.MDR-TB has a lower cure rate and treatment cost being almost 100 times more than treating a drug -susceptible TB patient, it is imperative that this problem be addressed on a priority . World Health Organization estimated TB prevalence and incidence rate of all forms of TB respectively 215 and 158 per 100 000 populations in 2014. With the introduction of Directly Observed Treatment Short course (DOTS) number of deaths has dramatically reduced from 9,712 (51/100 000) in 1990 to (17/100 000) in 2014. Total 35277 notifi ed new and relapse cases were detected, among the notifi ed new and relapse cases 345 (<1%) cases aged under 15 years. However male female ratio is 1.8 in 2014. Treatment success rate among new smear-positive cases was 91% for the cohort of patients registered in 2013, and has been consistently above the target of 85% since 2001. The success rate among new smear-negative/extra pulmonary and retreatment cases is high. (2) . Tuberculosis is one of the major public health problems in Nepal. About 45% of the total population is infected with TB, out of which 60% are in the productive age group. Every year about 44,000 people develop active TB, of whom 20,000 have infectious pulmonary disease. These 20,000 are able to spread the disease to others. In 1994 the National Tuberculosis Program (NTP) piloted Directly Observed Short Course (DOTS) in four districts with total population coverage of 1.7%. The Tuberculosis program is delivered in the 75 districts of Nepal through the Hospitals, Health Centers and Sub -Health Posts by staff for whom TB treatment is part of their integrated health care activities. In Nepal clinic based ambulatory treatment for Tuberculosis is the norm. Tuberculosis control is identifi ed as a top priority programme within the Ministry of Health and Population. Full DOTS institutional coverage was reached in the primary health system, including 100% coverage in PHC centers, health posts, and sub-health posts in the country. Decentralization of services, outreach projects and strong community involvement are contributing signifi cantly to increase case-detection and access to TB diagnosis and treatment.
SIZE OF THE MDR-TB PROBLEM IN NEPAL:
Anti tuberculosis drug resistance is a great public health problem, which may become a great challenge for the National TB control program. Of all patterns of drug resistance MDR -TB which is resistant to at least Rifampicin and Isoniazid is the one that focused international attention because of the reduced response to standard Short -Course Chemotherapy (SCC) with fi rst line drugs, leading to higher mortality and treatment failure rates and increased period of transmissibility. (2) Although its causes are microbial, clinical and programmatic, drug -resistant TB is eventually a man made phenomenon. An inadequate or poorly administered treatment regimen allows a drug resistant strain to become the dominant strain in a patient infected with TB. There are many studies conducted in the developed world to fi nd out causes of MDR -TB but in the developing world specially in the SAARC region such studies are scarce. Hence this study was conducted in Nepal to achieve the following objectives. To determine risk factors for multi-drug resistance in patients with pulmonary tuberculosis in Nepal.
METHODOLOGY:
Study Design
Institution based matched case -control study with a Case: Control ratio of 1:2 was carried out in order to identify the predisposing risk factors of MDR-TB in Nepal.
Study Setting
Selected institutions in Central Western and Eastern region in Nepal where the DOTS PLUS PILOT Project were carried out were the focal point for the study. (Kathmandu valley, Biratnagar and Pokhara) . These areas were selected considering feasibility and case load of MDR -TB patients in each region .
De nition of cases and controls
De nition of cases A sample of patients who were diagnosed as having MDR TB (sputum culture and sensitivity confi rmed) and who is permanent resident of Nepal were recruited for the study as a case.
Exclusion criteria:
MDR-TB patients less than 15 years of age.
De nition of controls
Controls were age -sex matched cured TB patients (who are not diagnosed as having MDR-TB) and who have completed TB treatment either from the same centre or any DOTS centre adjacent to that DOTS Plus centre.
Case: Control Ratio
To enhance the power of the study one case to two controls (1:2) were taken after consideration of the cost and precision of the study.
Matching
Two controls were matched with each case by a. Age (± 2 year) b. Sex (same) Sample size estimation and Sampling method Parameters used in the calculation of sample size: The proportion of the general population exposed to risk factors (P 0 ) and Odds Ratio worth detecting (R) are the parameters needed in calculation of the sample size of a case -control study according to the following equation In a situation where multiple risk factors are considered, the ideal would be to calculate the sample size using lowest proportion exposed among general population (P 0 ) and Odds Ratio associated with risk factor since it gives the largest sample size. After conducting thorough literature review prevalence of default from TB treatment will be taken as 25% for following reason. (4) It is (defaulter from TB treatment) considered as the one of the most important variable infl uencing the MDR -TB and this fi gure is considered relatively small fi gure compared to the proportion of the exposure due to other risk factors of MDR-TB. (E.g. substance abuse) Also this study is from developing country which is similar to Nepal context. Therefore the required sample size of 55 subjects was collected as a consecutive sample diagnosed as having MDR-TB in Nepal. Number of cases = 55 Number of controls = 110 Total number of subjects = 165
Sampling method for cases:
For this study following DOTS Plus centers and DOTS Centers were selected from Central, Western and Eastern region. (Table 1 ) Fifty fi ve MDR-TB cases were randomly selected from above centres using lottery method. Since proportionately higher number of cases are getting treatment from Central region more cases were recruited from Central region. Sampling method for controls: Age, sex matched controls were selected randomly from the cured TB patients which registered in the DOTS registry which is kept in the above centers.
If the DOTS Plus centre has no DOTS Centre, adjacent DOTS Centre was selected for the controls selection (Ex: NTC-Nepal is only a DOTS Plus centre, hence adjacent DOTS centers (Thimi Health Post ) was selected for this study. ) Controls were interviewed in their residence with prior appointment. Every effort was taken to preserve confi dentiality during interview.
Data Collection Technique
Data was collected by a team of researchers from National TB Programme, Nepal and SAARC TB and HIV/AIDS Centre using an interviewer administered, pre coded structured questionnaire for both cases and controls. Informed consent was obtained from all the cases and controls before interviewing them. The consent of the cases and controls was obtained in the same manner.
Ethical Consideration:
The following ethical issues were considered in the design of the study.  The cases and controls were briefed regarding the nature, objectives, and method of the study and their voluntary participation acquired.  Cases and controls were given the option to withdraw from the study at any point of time.  Total confi dentiality with regard to the identifi cation of the cases and controls was assured at all times during and after the study.  Permission and Consent were obtained from relevant authorities (National TB Control Programme) before commencement of the study. There was a signifi cant association of getting MDR-TB and previous history of TB, contact history of TB, HIV positive patients, non regularity of TB treatment, distance to DOTS clinic more than 5Km,and travel cost to treatment centre more than 50Nrs per day Final  tted model for multi variety analysis for the selected risk factors were done. Results are shown in Table 4 . Signifi cant oar-Adjusted Odds Ratio,df-Degree of freedom, Except not living in own house and having only one bed room all other variables which were signifi cant in the univariate analysis were signifi cant in the multy variety analysis.
Data collection instrument
DISCUSSION:
In the present study, the following factors were found as risk factors for MDR-TB: unemployment, unmarried civil status, those living in nuclear family, previous history of TB, contact history of TB, HIV positive status, non adherence to DOTS during previous treatment, travel cost to DOTS centre (more than 50 Nepali Rs), distance to DOTS centre (more than 5Km), and living in a rural area. A study done by Ahmed et al (2003) in Pakistan identifi ed history of TB treatment, being a male, belonging to 15-25 years age group, having 1-5 years of schooling or having TB patient in the household as a risk factors for MDR-TB (5) . According to the study conducted in Peru by Pablo et al (2003) , inadequate treatment regimen, poor adherence to treatment, and HIV infection were the risk factors for MDR-TB (6) . In a case control study conducted in four European countries it was found that IV drug usage, asylum -seeker support as income factor, living in a nursing home, previous TB with pulmonary location, living in a prison, known TB contacts , and Immune suppression other than HIV/ AIDS were the risk factors for MDR-TB (7) . In the present study HIV infection was found to be as a risk factor for MDR-TB in Nepal. As reported in other studies from Sub Saharan Africa, and the recent Global project on drug resistance, no signifi cant association was observed between the MDR-TB and HIV infection status in the new cases of MDR-TB (8)(9)(10) (11) . Numerous MDR-TB outbreaks have been documented in HIV patients, and in some One notable fi nding in the present study was that diffi cult and accessibility to health services due to the distance from the health centre being more than 5 Kms. was associated with one getting MDR-TB. The results suggests that patients with MDR-TB coming to the DOTS centre from more than 5Km away are at a great risk of developing MDR TB than patients living nearby to the health services facilities. High travel cost (more than 50 NRs) may lead to poor patient compliance and be considered as a risk factor for MDR-TB. Previous studies have revealed that the non complaint patients spent more time and cost for traveling to the treatment centre than the compliant patients. The time spent traveling to the centre could be used for other purposes. For those in employment, travel time represents time absent from work. Hence, non compliance with TB treatment was one of the strongest predictors of MDR-TB. Non compliance with treatment is not only harmful for the patients, but its consequence may be much more severe for the general population. The substantially higher risk of MDR-TB among unemployed patients is possibly a function of socio economic status. Unemployment may have served as an indirect measure of the patient's functional and socio-economic status. Impoverished populations are well documented in many setting to have higher rates of TB than the general population. The cycle between poverty and TB is broadly recognized (13) . Unmarried civil status was a risk factor for MDR-TB. On the premise that patients are less likely to default if they live with many family members mainly with wife and children who provide encouragement and remind to keep medical appointments than living alone or living with friends, In the present study those individuals present in rural areas were at high risk for MDR-TB compared to urban areas as the rural inhabitants do not have the same level of access to health and social services as their urban counterpart. Similar fi ndings were reported in study done by Boyte et al 2001 (14) . Patients in the present study who smoked tobacco were considered as at risk for MDR-TB. However it was statistically not found to be risk factor. Though previous studies have reported that alcoholism is an important risk factor for MDR-TB, our study did not reveal that alcoholism contributed to MDR-TB. (15) .
Previous studies reported previous history of tuberculosis treatment is a signifi cant risk factor for developing MDR-TB as in the present study (14) . The present study revealed that previous TB treatment is a risk factor for MDR-TB. In a study of 876 patients in a 6 countries, the re-treatment success rate was 57% and 29% with MDR-TB (16) . Previous resistance surveillance conducted in Nepal also revealed higher rates of MDR-TB among re-treatment group (17) .These results suggest that the higher incidence of MDR-TB were inevitably associated with lower success rate in re treatment group. Contact with a TB patient at home, in the work place, or elsewhere was a risk factor. These fi ndings might be affected by recall bias because cases were perhaps more likely to remember a history of exposure than controls.
CONCLUSION:
1. Despite a successful implementation of a TB control programme in Nepal, drug resistant TB remains an important issue. 2. HIV sero-positivity (OR=15.9) was signifi cantly associated with MDR-TB in Nepal 3. Travel cost of more than 50 NPR per day (OR=6.5) and distance of more than 5 KM to DOTS centers were signifi cant risk factors for MDR-TB. 4. Previous history of TB, contact history of TB (OR=3.8) and previous non adherence to
